AI Driven Approaches to Trial Design Innovation

At Unlearn, our goal is to inform, advance, and accelerate research to help bring new treatments to patients who need them faster. Leveraging sophisticated machine learning and historical patient data, we generate new evidence — Digital Twins, or predicted placebo outcomes for each patient in a trial. Clinical trials powered by Digital Twins provide greater statistical power to answer existing and new research questions, in a shorter time frame, and are easy to integrate into protocols and analysis plans. In this whitepaper, we provide an overview of Digital Twins and how this innovation makes it possible to prospectively design smaller trials with higher statistical power, or to recover power in ongoing trials impacted by low enrollment or high dropout rates.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
White Papers

Applications of Digital Twins in Clinical Trials for Alzheimer’s Disease


Unlearn.AI named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups


Welcoming Dr. Taylor to Unlearn.AI’s Board of Directors

I’m honored to have such an inspirational and experienced leader like Dr. Taylor join our board.
The AI 100 is CB Insights' annual list of the 100 most promising private AI companies in the world.
How Digital Twins make it possible to design and run more efficient clinical trials with well-defined statistical properties.